Correlation Between Cell Source and Rasna Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cell Source and Rasna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cell Source and Rasna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cell Source and Rasna Therapeutics, you can compare the effects of market volatilities on Cell Source and Rasna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cell Source with a short position of Rasna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cell Source and Rasna Therapeutics.

Diversification Opportunities for Cell Source and Rasna Therapeutics

0.09

Correlation Coefficient

Cell Source  Rasna Therapeutics

Significant diversification

The 3 months correlation between Cell and Rasna is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Cell Source and Rasna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rasna Therapeutics and Cell Source is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cell Source are associated (or correlated) with Rasna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rasna Therapeutics has no effect on the direction of Cell Source i.e., Cell Source and Rasna Therapeutics go up and down completely randomly.

Pair Corralation between Cell Source and Rasna Therapeutics

Given the investment horizon of 90 days Cell Source is expected to generate 17.82 times less return on investment than Rasna Therapeutics. But when comparing it to its historical volatility, Cell Source is 10.78 times less risky than Rasna Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Rasna Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.40  in Rasna Therapeutics on May 12, 2025 and sell it today you would earn a total of  0.00  from holding Rasna Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Cell Source  vs.  Rasna Therapeutics

Cell Source

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Cell Source are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cell Source unveiled solid returns over the last few months and may actually be approaching a breakup point.

Rasna Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Rasna Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Rasna Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cell Source and Rasna Therapeutics

The main advantage of trading using opposite Cell Source and Rasna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cell Source position performs unexpectedly, Rasna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rasna Therapeutics will offset losses from the drop in Rasna Therapeutics' long position.

The idea behind Cell Source and Rasna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.